PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals today announced the final 60-month follow-up data from the Phase 3 study of ADSTILADRIN ® (nadofaragene firadenovec-vncg) were presented at ...
Building performance is a hallmark of architecture in the 21st century. With buildings and the construction industry being significant contributors to carbon emissions, designers must do everything to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results